Global Hemorrhoids Treatment Market Size, Share, Forecast Report, 2020-2027

The Global Hemorrhoids Treatment Market is expected to register a CAGR of ~5.5 % during the forecast period of 2018 to 2023.One of the most uncomfortable disorders a patient can have is hemorrhoids and most of the population under the age of fifty don’t know what hemorrhoids are. The general population avoids the disorder until they suffer from the disorder and start to feel the symptoms such as pain and itching associated with the condition. According to the American Society of Colon & Rectal Surgeons, hemorrhoids are one of the most common disorders and more than half the population will develop hemorrhoids after the age of 30. The prevalence of hemorrhoids (also called piles) in the United States is reported to be 4.4% with most suffering occurring between the ages of 45 and 65, equally in men and women. But only one third of these individuals seek medical treatment such as surgery, medication etc., with most opting for over-the-counter relief purchased from the pharmacies.

There are two types of haemorrhoids (piles), internal and external, which differ to their location. While there is no exact cause of hemorrhoids, there variety of reasons that can subsidize to the disorder: aging, chronic constipation or diarrhea, pregnancy, heredity, straining during bowel movements, faulty bowel function. Some patients may not even experience symptoms but those that do may notice bleeding during bowel movements, protrusion during bowel movements and itching, pain, and sensitive lumps in the anal area. A variety of options exist for home treatment such as sitz baths, wipes, suppositories, creams, fiber supplements, and hemorrhoid pillows. Over half of patients purchasing hemorrhoid treatment use a cream. Preparation H and Tucks are the leading providers of creams, wipes/pads, and suppositories and can be purchased at most grocery and drug stores.
Segmentation:

The Global Hemorrhoids Treatment Market is segmented based on treatment type, route of administration, distribution channel, and region.On the basis of treatment type, the market is segmented into drugs (further sub segmented into laxatives, NSAIDs, and herbals) non-surgical procedures (further sub segmented into band litigation, sclerotherapy, cryotherapy) surgical procedures. Further, on the basis of route of administration the market is segmented into oral, topical agents. Distribution channel is segmented into retail pharmacies, hospital pharmacies, online pharmacies and others.

Key players:

Some of the key players in the Global Hemorrhoids Treatment Market are Abbott Laboratories, AstraZeneca plc, Bayer AG, Boehringer Ingelheim GmbH, Boston Scientific Corporation, CONMED Corporation, Cook Medical, GlaxoSmithKline, Olympus Corporation, Pfizer Inc., Takeda Pharmaceutical Company, Taro pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd, Astra Zeneca, Glenmark Pharmaceuticals and others

Market Segmentation and Key Market Players

Global Hemorrhoids Treatment Market, by Treatment Type:

• Drugs
• Non-surgical procedures
• Surgical procedures

Global Hemorrhoids Treatment Market, by Route of Administration:

• Oral
• Topical Agents

Global Hemorrhoids Treatment Market, by Distribution Channel:

• Retail pharmacies
• Hospital pharmacies
• Online pharmacies
• Others

Global Hemorrhoids Treatment Market, by Key Players:

• Abbott Laboratories
• AstraZeneca plc
• Bayer AG
• Boehringer Ingelheim GmbH
• Boston Scientific Corporation
• CONMED Corporation
• Cook Medical
• GlaxoSmithKline
• Olympus Corporation
• Pfizer Inc.
• Takeda Pharmaceutical Company
• Taro pharmaceuticals Inc.
• Teva Pharmaceutical Industries Ltd
• Astra Zeneca
• Glenmark Pharmaceuticals